Patheon is a global provider of development and commercial manufacturing services for solid and sterile prescription drugs, offering a wide variety of services and products. SEE AND Read More »

Want to learn more?

Patheon Overview Brochure

Method Development and Validation

Patheon offers the full breadth of advanced technologies for the analytical method development and validation in support of drug product development leading to NDA and ANDA submissions. Our analytical services include:

  • Method Validation in accordance with ICH Q2 and USP requirements
  • Protocol driven stability studies

By having analytical method development and validation seamlessly integrated into a complete development program driven by an experienced dedicated team, Patheon is the most rapid and cost-effective way to go from molecule to market.

Method Development and Validation Studies

  • Cleaning residual assays
  • Stability indicating assays by UPLC, HPLC, and GC (including forced degradation studies)
  • Related substances, chiral purity, residual solvents determinations
  • Dissolution testing
  • Preservative assays
  • Physical methods (laser diffraction, Karl Fisher)
  • Nasal spray characterization (droplet size, spray pattern, spray content uniformity)

Case Study: Method Development and Validation That Keeps Projects On Track

The Challenge A customer came to Patheon needing clinical trial materials for their peptide product. When transferred to Patheon the validation of the HPLC methods was insufficient and poorly reproducible. This issue had the potential to delay the clinical trials and adversely affect the project’s overall timeline.

The Solution Patheon's experienced team identified and modified the critical parameters, then produced robust, fully validated HPLC analytical methods.

The Outcome The customer received the clinical trial material, and was able to keep their project moving forward on schedule.

Ask The Experts

Geoff Carr, Ph.D.

Geoff Carr, Ph.D.
Dr. Carr offers Patheon customers 36 years of applying analytical science to the creation of pharmac
Read More »

Rodney Pearlman, PhD.

Rodney Pearlman, PhD.
An expert in the development of scientific and business strategies for start-ups, Dr. Pearlman bring
Read More »

William E. Weiser, Ph.D.

William E. Weiser, Ph.D.
Dr. Weiser is an expert in analytical method development and validation for APIs and drug products.
Read More »

View All »

Knowledge Library


Please fill the below form to access requested content

First Name

Last Name

Company

Title

Email

Phone

Address Line 1

Address Line 2

City

Zip/ Postal Code

Country

Submit